Evaluation of the Effectiveness of a Rehabilitation Program for Hearing and Communication Disorders in Elderly People in Nursing Homes.
NCT ID: NCT07321691
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2026-02-28
2028-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation and Evaluation of the French Version of a Hearing Loss Screening Questionnaire in Adults Aged 60 Years Old and More
NCT04159428
Evaluation of the Quality of Life After a Multidisciplinary Auditory Rehabilitation Program
NCT05228769
Effect of an Aural Rehabilitation Program in Hearing-impaired Older Adults
NCT05083221
Hearing Aids Use in Elderly: Efficacy in Speech Perception and in Health-related Quality of Life
NCT04333043
Evaluation of Hearing Aids Rehabilitation Within Age-related Hearing Loss Population.
NCT05331404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This program includes for the resident:
* the alternative use of two hearing rehabilitation devices aimed to improve audibility
* An inaugural training led by a trained professional to promote oral communication The effectiveness of the two devices will be compared.
This program includes for the staff members:
\- A one-day training comprising three components (general concepts concerning deafness and its rehabilitation, training in the use of the device to improve audibility, training in facilitating the communication workshop).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transmitter with receiver
hearing rehabilitations : a transmitter with several receivers
use of hearing rehabilitation device
the use hearing rehabilitation devices aimed to improve audibility
listening assistant.
one type of hearing rehabilitations
use of hearing rehabilitation device
the use hearing rehabilitation devices aimed to improve audibility
No hearing device
no hearing device
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
use of hearing rehabilitation device
the use hearing rehabilitation devices aimed to improve audibility
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with an MMS (Mini Mental State) score\> 15
* with a GIR Group ≥ à 3 affiliated to a social security scheme
* French speaking
Exclusion Criteria
* having followed a similar training program
* Subjects under juridical protections or tutelage measure
* unable to answer questions and participate in group activities
* with associated life-threatening pathologies and/or a life expectancy in EHPAD of less than 6 months
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A01543-46
Identifier Type: OTHER
Identifier Source: secondary_id
RC31/23/0390
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.